NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	UTI-Healthcare Fund - Direct (G)
Fund Type	Equity
Risk	Very High
Min SIP Amount	₹500
Min Lumpsum	₹5,000
Expense Ratio	1.34%
NAV	₹400.53 (11 Nov 2026)
Fund Size	₹1,432.88 Cr
Fund Started	01 Jan 2013
Lock-in Period	No lock-in
Exit Load	1.00%If redeemed / switched out less than one year from the date of allotment NilIf redeemed / switched out greater than or equal to one year from the date of allotment

Trailing risk-adjusted performance measures

Name	Assets
Sun Pharmaceutical ...Equity	7.44%
Divis Laboratories LtdEquity	6.46%
Dr Reddys Laborator...Equity	5.78%
Ajanta Pharma LtdEquity	4.29%
Max Healthcare Inst...Equity	4.20%
Gland Pharma LtdEquity	3.89%
Apollo Hospitals En...Equity	3.83%
Alkem Laboratories LtdEquity	3.66%
Lupin LtdEquity	3.65%
Global Health LtdEquity	3.37%

Fund Manager	UTI-Healthcare Fund - Direct (G)
Name
Managing Since	02 May 2022